Yibin Xiang
Inventor
Stats
- 19 US patents issued
- 39 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 19 US Patents Issued
- 39 US Applications Filed
- 463 Total Citation Count
- Jul 19, 2024 Most Recent Filing
- Aug 4, 1993 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
Changzhou Jiekai Pharmatech Co., Ltd. | 1
| 2014
|
GENZYME CORPORATION | 4
3 2 4 2 3 2 2 1 | 2008
2009 2010 2012 2013 2014 2015 2016 2017 |
Biota Scientific Management Pty Ltd. | 2
| 2004
|
OSCIENT PHARMACEUTICALS CORPORATION | 1
| 2004
|
PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2
| 2010
|
TAIGEN BIOTECHNOLOGY | 8
5 1 | 2004
2005 2007 |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2
| 2010
|
TAIGEN BIOTECHNOLOGY CO., LTD. | 1
2 1 | 2004
2005 2007 |
GENETICS INSTITUTE, LLC | 3
2 | 2000
2002 |
MERCK FROSST CANADA LTD. | 1
| 1993
|
ARQULE, INC. | 2
| 2004
|
AMERICAN HOME PRODUCTS CORPORATION | 1
| 2002
|
Inventor Addresses
Address | Duration |
---|---|
Acton, MA | Dec 31, 02 - Dec 09, 08 |
Acton, MA, US | Aug 14, 03 - Apr 05, 18 |
Dracut, MA, US | Sep 11, 14 - Jan 23, 25 |
Lexington, MA | Sep 27, 94 - Sep 27, 94 |
Waltham, MA, US | Oct 14, 10 - Jan 21, 14 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 34 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 5 |
C07C: | ACYCLIC OR CARBOCYCLIC COMPOUNDS | 2 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2025/0026,749 | 2025 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | 0 |
2024/0423,952 | 2024 | COMPOSITIONS AND METHODS FOR TREATING CONGENITAL DISORDERS | 0 |
12060349 | 2024 | Glucosylceramide synthase inhibitors | 0 |
2022/0073,508 | 2022 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | 0 |
2021/0261,557 | 2021 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | 3 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.